GE HealthCare Technologies EBITDA 2020-2023 | GEHC
- GE HealthCare Technologies EBITDA for the quarter ending December 31, 2023 was $0.833B, a 10.81% decline year-over-year.
- GE HealthCare Technologies EBITDA for the twelve months ending December 31, 2023 was $3.045B, a 3.49% decline year-over-year.
- GE HealthCare Technologies 2023 annual EBITDA was $3.045B, a 3.49% decline from 2022.
- GE HealthCare Technologies 2022 annual EBITDA was $3.155B, a 7.75% decline from 2021.
- GE HealthCare Technologies 2021 annual EBITDA was $3.42B, a 2.09% increase from 2020.
GE HealthCare Technologies Annual EBITDA (Millions of US $) |
|
---|---|
2023 | $3,045 |
2022 | $3,155 |
2021 | $3,420 |
2020 | $3,350 |
2019 | $2,783 |
GE HealthCare Technologies Quarterly EBITDA (Millions of US $) |
|
---|---|
2023-12-31 | $833 |
2023-09-30 | $770 |
2023-06-30 | $726 |
2023-03-31 | $716 |
2022-12-31 | $934 |
2022-09-30 | $765 |
2022-06-30 | $788 |
2022-03-31 | $668 |
2021-12-31 | |
2021-09-30 | |
2020-12-31 | |
2019-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $37.024B | $19.552B |
Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Inspire Medical Systems (INSP) | United States | $4.855B | 0.00 |
Axonics (AXNX) | United States | $3.435B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.072B | 0.00 |
10x Genomics (TXG) | United States | $3.022B | 0.00 |
Azenta (AZTA) | United States | $3.015B | 163.85 |
Olink Holding AB (publ) (OLK) | Sweden | $2.918B | 0.00 |
Enovis (ENOV) | United States | $2.779B | 20.60 |
Hims & Hers Health (HIMS) | United States | $2.603B | 0.00 |
Privia Health (PRVA) | United States | $2.238B | 99.26 |
Schrodinger (SDGR) | United States | $1.679B | 0.00 |
Omnicell (OMCL) | United States | $1.376B | 47.56 |
Phreesia (PHR) | United States | $1.237B | 0.00 |
Standard BioTools (LAB) | United States | $0.650B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.636B | 0.00 |
Definitive Healthcare (DH) | United States | $0.631B | 0.00 |
Talkspace (TALK) | United States | $0.451B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.431B | 0.00 |
Health Catalyst (HCAT) | United States | $0.393B | 0.00 |
Pulmonx (LUNG) | United States | $0.342B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.300B | 0.00 |
P3 Health Partners (PIII) | United States | $0.236B | 0.00 |
Outset Medical (OM) | United States | $0.214B | 0.00 |
Butterfly Network (BFLY) | United States | $0.201B | 0.00 |
American Well (AMWL) | United States | $0.150B | 0.00 |
Augmedix (AUGX) | United States | $0.128B | 0.00 |
TruBridge (TBRG) | United States | $0.121B | 5.17 |
MSP Recovery (LIFW) | United States | $0.120B | 0.00 |
111 (YI) | China | $0.094B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.079B | 0.00 |
Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.061B | 0.00 |
HeartBeam (BEAT) | United States | $0.055B | 0.00 |
Zepp Health (ZEPP) | China | $0.051B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.049B | 0.00 |
Movano (MOVE) | United States | $0.039B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
Akili (AKLI) | United States | $0.032B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
Cue Health (HLTH) | United States | $0.021B | 0.00 |
CareCloud (CCLD) | United States | $0.017B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
Syra Health (SYRA) | United States | $0.012B | 0.00 |
Biotricity (BTCY) | United States | $0.011B | 0.00 |
ETAO (ETAO) | United States | $0.010B | 0.00 |
Transgenomic (PRPO) | United States | $0.008B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
HeartSciences (HSCS) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |